← k3vl4r
Log inGet started →

ABT (Abbott Laboratories) Price Forecast

AI-generated price forecast for Abbott Laboratories (ABT) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads ABT as 2/3 bearish across its horizons (1 of 3 timeframes pointing up), with a last price of 104.30. Measured over its last 1039 resolved 4-hour forecasts (30-day window), the model's direction call on ABT was correct 65% of the time. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP🎯 Top Pick analysis🔬 Deep research

Last price

104.30

AI outlook

2/3 bearish

Timeframes up

1 / 3

Measured 4-hour accuracy

65%

1039 resolved forecasts · 30d window

Share𝕏PostTelegram

ABT forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour~6 days out▲ Up+1.26%
4-hour~3 weeks out▼ Down-2.59%
Daily~4 weeks out▼ Down-6.60%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called ABT's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Congressional trades in ABT

Public STOCK Act disclosures · amounts are ranges, reported up to ~45 days after the trade.

MemberActionDateAmount
Pete Sessions (spouse)▼ Sell2026-10-02$50001–100000
Gilbert Cisneros▲ Buy2026-09-18$1001–15000
Thomas H. Kean▼ Sell2026-09-17$1001–15000
Richard Dean Dr McCormick▼ Sell2026-07-30$1001–15000
Mike Kelly (spouse)▼ Sell2026-07-17$1001–15000

22 disclosures in the last year. Track what Congress is trading across the whole market in the app — get started free.

Latest ABT news

From the market-news feed the forecasts are read against.

  • Abbott (ABT) Stock May Be 28% Undervalued Despite AI Testing Expansion · Yahoo · Nov 17
  • Non-Animal Alternative Testing - Global Strategic Business Report 2026: Capitalize on 13.3% CAGR and $4.7B by 2032 as Abbott, Charles River, Emulate, Evotec, and Bio-Rad Reshape Testing · Yahoo · Nov 16
  • Global Point of Care (POC) Immunoassay Analyzer Expansion Market 2026 | Capture 8.8% CAGR to 2030 as Roche, Abbott, Siemens Healthineers and Danaher Scale AI-Enabled POC Testing · Yahoo · Nov 16
  • Abbott Laboratories Extends Change in Control Agreements to December 31, 2028 · Fintel · Nov 16
  • Here's How Abbott's EP Business Is Shaping Up for the Rest of 2026 · Yahoo · Nov 16

🔒

See the full ABT forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

ABT forecast — frequently asked

Will ABT go up?

K3vl4r's calibrated AI forecast currently reads ABT as 2/3 bearish — 1 of 3 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

How accurate is the ABT AI forecast?

Measured over its last 1039 resolved 4-hour forecasts (30-day window), the model's direction call on ABT was correct 65% of the time. Accuracy is recomputed continuously against resolved outcomes and varies by symbol, horizon and market regime; past accuracy does not guarantee future results. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the ABT price prediction for 2026?

K3vl4r's model projects ABT toward $106.08 over the next ~6 days, a +1.3% move from $104.76. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could ABT reach?

Over its longest horizon (~~4 weeks), the model's projected target for ABT is $97.84 (-6.6% vs $104.76). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

MTDHCATECHTMODHRCHEILMNQGENCAHACHCCVSAENSGWAT

Will ABT reach…?

Will ABT reach $200.00?Will ABT reach $250.00?Will ABT reach $500.00?

Or see the full ABT price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare ABT

ABT vs MTDABT vs HCAABT vs TECHABT vs TMOABT vs DHRABT vs CHE

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.